Listing 3 - Actual negotiations

Indication:

HIV-1 infection, pre-exposure prophylaxis

Indication:

Advanced prostate cancer

Indication:

Febrile neutropenia in non-myeloid malignancies

Indication:

Antineutrophil cytoplasmic antibody-associated vasculitis

Indication:

Phenylketonuria

Indication:

In combination with pemetrexed and platinum-based chemotherapy for the first-line treatment of patients with locally advanced (not amenable to curative therapies), or metastatic NSCLC whose tumours have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations

Indication:

Fibrodysplasia Ossificans Progressiva

Indication:

For the treatment of adult patients with previously untreated chronic lymphocytic leukemia (CLL), including those with 17p deletion (in combination with Imbruvica)

Indication:

Waldenström's Macroglobulinemia

Indication:

In combination with venetoclax for the treatment of adult patients with previously untreated chronic lymphocytic leukemia (CLL), including those with 17p deletion.